Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24628797)

1.

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.

van der Pol P, Liebregts N, Brunt T, van Amsterdam J, de Graaf R, Korf DJ, van den Brink W, van Laar M.

Addiction. 2014 Jul;109(7):1101-9. doi: 10.1111/add.12508. Epub 2014 Mar 17.

PMID:
24628797
2.

Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

Freeman TP, Morgan CJ, Hindocha C, Schafer G, Das RK, Curran HV.

Addiction. 2014 Oct;109(10):1686-94. doi: 10.1111/add.12634. Epub 2014 Jul 16.

PMID:
24894801
3.

Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

Hunault CC, Mensinga TT, de Vries I, Kelholt-Dijkman HH, Hoek J, Kruidenier M, Leenders ME, Meulenbelt J.

Psychopharmacology (Berl). 2008 Dec;201(2):171-81. doi: 10.1007/s00213-008-1260-2. Epub 2008 Aug 10.

PMID:
18695931
4.

Validation of self-reported cannabis dose and potency: an ecological study.

van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M.

Addiction. 2013 Oct;108(10):1801-8. doi: 10.1111/add.12226. Epub 2013 May 30.

PMID:
23627816
5.

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Hunault CC, Mensinga TT, Böcker KB, Schipper CM, Kruidenier M, Leenders ME, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2009 May;204(1):85-94. doi: 10.1007/s00213-008-1440-0. Epub 2008 Dec 20.

PMID:
19099294
6.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.

Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA.

Clin Chem. 2013 Dec;59(12):1770-9. doi: 10.1373/clinchem.2013.207316. Epub 2013 Aug 12.

7.

Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model.

Hunault CC, van Eijkeren JC, Mensinga TT, de Vries I, Leenders ME, Meulenbelt J.

Toxicol Appl Pharmacol. 2010 Aug 1;246(3):148-53. doi: 10.1016/j.taap.2010.04.019. Epub 2010 May 4.

PMID:
20450927
9.

Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.

Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H.

Psychopharmacology (Berl). 1981;74(3):208-12.

PMID:
6267648
10.

Tetrahydrocannabinol content and differences in marijuana smoking behavior.

Herning RI, Hooker WD, Jones RT.

Psychopharmacology (Berl). 1986;90(2):160-2.

PMID:
3024196
11.

Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.

Korf DJ, Benschop A, Wouters M.

Int J Drug Policy. 2007 May;18(3):168-76. Epub 2006 Sep 25.

PMID:
17689363
12.
13.

Passive cannabis smoke exposure and oral fluid testing.

Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ.

J Anal Toxicol. 2004 Oct;28(7):546-52.

14.

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.

Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ.

J Anal Toxicol. 2005 Oct;29(7):607-15.

15.

Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.

Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM.

J Pharmacol Exp Ther. 1992 Apr;261(1):114-22.

PMID:
1313866
16.

Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.

Psychopharmacology (Berl). 2002 Jun;161(4):331-9. Epub 2002 Apr 19.

PMID:
12073159
17.

Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.

Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G.

Psychopharmacology (Berl). 2011 Mar;214(2):391-401. doi: 10.1007/s00213-010-2042-1. Epub 2010 Oct 30.

18.

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.

Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B.

Drug Alcohol Depend. 2007 Jan 5;86(1):22-9. Epub 2006 Jun 12.

PMID:
16769180
19.

Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking.

Matthias P, Tashkin DP, Marques-Magallanes JA, Wilkins JN, Simmons MS.

Pharmacol Biochem Behav. 1997 Dec;58(4):1145-50.

PMID:
9408226
20.

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.

Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR.

J Psychopharmacol. 2009 May;23(3):266-77. doi: 10.1177/0269881108092393. Epub 2008 Aug 21.

PMID:
18719045
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk